SAN CLEMENTE, CA -- (MARKET WIRE) -- 03/09/06 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it has recently surpassed 1,000 unit sales of the Waterlase MD(TM) laser system. BIOLASE believes the Waterlase MD is the most advanced all-tissue laser system available in the dental market. Notable features include the HydroBeam(TM) LED illuminated contra-angle handpiece and SensaTouch(TM) laser control touch screen coupled with innovative, ergonomic styling and design based on BIOLASE's proprietary HydroPhotonic(TM) technology platform. The Company has sold its Waterlase MD laser systems to dentists in over 45 countries since its launch in October 2004 at the American Dental Association (ADA) Annual Meeting.

"To have reached this milestone in a short period of time is a significant accomplishment for the Company," commented Robert E. Grant, President and CEO. "We are pleased that the Waterlase MD has become the Company's best-selling dental laser system. As the dental laser market continues to expand, we are confident that our leadership position will be strengthened as more dentists adopt laser technology for their practices. To note, we are pleased to report that the Company has sold more than 6,000 total laser systems worldwide since its inception."

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com) is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase® system, is one of the best selling dental laser systems. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile(TM) system, which uses a laser to perform soft tissue and cosmetic procedures, including tooth whitening.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, including, without limitation, the impact of changes in demand for our products, our effectiveness in managing manufacturing costs and expansion of our operations, the impact of technological advances and competition, adoption of our products by dental practitioners, our ability to expand our direct sales force, the timely and effective implementation of strategic alternatives and overall economic and market conditions. Additional information concerning these and other risks are described in the Company's periodic reports it files with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2004 and its quarterly report on Form 10-Q for the quarter ended September 30, 2005. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

For further information, please contact:
Robert E. Grant
President & CEO

Richard L. Harrison
Executive Vice President and CFO

Scott Jorgensen
Vice President - Business Development

BIOLASE Technology, Inc.
+1-949-361-1200